Trius and General Market Commentary 6/5/13.. Answering critics and explaining market cap to price. Business basics as well.
Trius Therapeutics: The Next Big Small-Cap Biotech Mover?
Normally, I write about biotech companies with near-term catalysts I feel offer traders good long based trade opportunities heading into these catalysts. Every so often, I find a small cap biotech where I feel a speculation investment is truly warranted.…
Biotech Buyout Speculation: Trius Could Be Acquired Very Soon
Trius Therapeutics, Inc. (TSRX) focuses on the discovery, development, and commercialization of antibiotics for serious infections. It develops tedizolid phosphate that has completed phase 3 clinical trial for the treatment of acute bacterial skin and skin structure infections; and completed…
Trius Additional DD, Excerpts from Aegis Analyst Report (Premium Members Only)
Investment Highlights: ■ Raising Price Target – Filing Expected This Year. Early this morning, Trius reported positive data from its second Phase 3 trial of tedizolid phosphate (TR-701), the firm’s lead drug candidate for the treatment of bacterial infections. In…
Video Chart Analysis and Commentary on Trius Therapeutics ($TSRX)
Video Chart analysis and commentary on Trius Therapeutics (TSRX). From the Aegis analyst report, we read the following: In the wake of this data, we are raising our probability of success for tedizolid from 60% to 80%, which increases the…
4 Top Small Cap Biotech Acquisition Targets
Today, I list small cap companies I believe are top acquisition targets for large pharma. I combine speculation, rumors and buzz I am hearing, and company financial position as a few factors for consideration. Buy-outs are hard to predict in…
Updated:Trade Call Opinion: $TSRX For a Bounce Back Over $8
Today TSRX bounced off about $7.50 again, which has proven to be a solid level of support. On the below 60 minute, 20-day chart we can see that it is setting up to make a move to back around $8.00…
Long Trade Call: Five Star Quality Care Inc. $FVE
Five Star Quality Care, Inc(FVE) is a national healthcare and senior living provider, offers the highest quality of care and service. Five Star has two major operating divisions: Five Star Senior Living and Five Star Rehabilitation Services. The Five Star Senior…
BioDelivery Sciences Primed To Grab Its Share Of The $1.5 Billion Opioid Market
These days, prescription drugs have become a source for legal and illegal abuse. This abuse can lead to a medical diagnosis called opioid dependence, which is when a patient that is addicted to opioids such as morphine, hydrocodone, oxycodone, or…
Mannkind Thesis – Bearish $MNKD
In my opinion, investors need to be careful of the current MNKD stock run up. It’s likely it’s manipulation being pulled off by the warrant holders in order for them to cash out with good profit. Company has ZERO chance…
